Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.16% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Healthcare | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Costco
COST
$427B
| $75.7M | 0.04% |
362,306
+229,233
| +172% | +$45.3M |
|
477
CALL
Pfizer
PFE
$153B
| $75.7M | 0.04% |
2,199,171
+720,093
| +49% | +$24.6M |
|
478
Golar LNG
GLNG
$5.21B
| $75.7M | 0.04% |
2,568,769
+182,996
| +8% | +$5.56M |
|
|
MASI
479
DELISTED
Masimo
MASI
| $75.5M | 0.04% |
773,023
-217,306
| -22% | -$20.7M |
|
480
Cisco
CSCO
$447B
| $75.5M | 0.04% |
1,754,200
-4,995,216
| -74% | -$218M |
|
|
RTN
481
CALL
DELISTED
Raytheon Company
RTN
| $75.4M | 0.04% |
390,300
+111,800
| +40% | +$23.5M |
|
482
Weyerhaeuser
WY
$17.9B
| $75.2M | 0.04% |
2,063,132
+1,386,138
| +205% | +$50.7M |
|
483
CALL
Philip Morris
PM
$294B
| $75M | 0.04% |
928,900
+607,800
| +189% | +$51.6M |
|
|
AGN
484
CALL
DELISTED
Allergan plc
AGN
| $74.8M | 0.04% |
448,700
-141,900
| -24% | -$22.8M |
|
485
CALL
Teva Pharmaceuticals
TEVA
$42.6B
| $74.8M | 0.04% |
3,074,900
+836,700
| +37% | +$17.1M |
|
486
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $74.4M | 0.04% |
+1,416,830
| New | +$79.4M |
|
487
PUT
lululemon athletica
LULU
$13.6B
| $74.3M | 0.04% |
595,000
+342,100
| +135% | +$36.5M |
|
488
CALL
Las Vegas Sands
LVS
$29.6B
| $74.2M | 0.04% |
971,900
+544,400
| +127% | +$41.6M |
|
489
Archer Daniels Midland
ADM
$38.6B
| $74M | 0.04% |
1,614,895
+1,592,874
| +7,233% | +$71.5M |
|
|
ISBC
490
DELISTED
Investors Bancorp, Inc.
ISBC
| $73.8M | 0.04% |
5,769,633
-489,229
| -8% | -$6.59M |
|
491
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $73.8M | 0.04% |
671,900
+209,500
| +45% | +$22.4M |
|
492
PUT
Honeywell
HON
$74.2B
| $73.7M | 0.04% |
566,671
+35,091
| +7% | +$4.67M |
|
493
PUT
CVS Health
CVS
$121B
| $73.6M | 0.04% |
1,143,600
+291,400
| +34% | +$19.2M |
|
494
PUT
Weibo
WB
$1.88B
| $73.5M | 0.04% |
827,700
+507,000
| +158% | +$55.1M |
|
495
Packaging Corp of America
PKG
$22.9B
| $73.2M | 0.04% |
654,550
+339,768
| +108% | +$39.7M |
|
496
DuPont de Nemours
DD
$19.5B
| $72.7M | 0.04% |
435,754
+363,896
| +506% | +$60.9M |
|
497
Cheesecake Factory
CAKE
$5.57B
| $72.7M | 0.04% |
1,319,817
+1,101,629
| +505% | +$58.3M |
|
|
STAY
498
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $72.3M | 0.04% |
3,347,686
+456,195
| +16% | +$9.34M |
|
499
PUT
Arista Networks
ANET
$257B
| $72M | 0.04% |
4,473,600
+366,400
| +9% | +$5.98M |
|
500
Dollar General
DG
$26.9B
| $71.9M | 0.04% |
729,649
+477,533
| +189% | +$45.9M |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.